These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36692636)
21. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929 [TBL] [Abstract][Full Text] [Related]
22. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045 [TBL] [Abstract][Full Text] [Related]
23. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population. Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589 [TBL] [Abstract][Full Text] [Related]
24. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Ben Bouallègue F; Mariano-Goulart D; Payoux P; J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345 [TBL] [Abstract][Full Text] [Related]
25. Weng R; Ren S; Su J; Ni W; Yang C; Gao X; Xiao W; Zhang X; Jiang H; Guan Y; Huang Q; Gu Y Brain Imaging Behav; 2023 Apr; 17(2):185-199. PubMed ID: 36637715 [TBL] [Abstract][Full Text] [Related]
26. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging. Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132 [TBL] [Abstract][Full Text] [Related]
27. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Delorme C; Paccoud O; Kas A; Hesters A; Bombois S; Shambrook P; Boullet A; Doukhi D; Le Guennec L; Godefroy N; Maatoug R; Fossati P; Millet B; Navarro V; Bruneteau G; Demeret S; Pourcher V; Eur J Neurol; 2020 Dec; 27(12):2651-2657. PubMed ID: 32881133 [TBL] [Abstract][Full Text] [Related]
28. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821 [TBL] [Abstract][Full Text] [Related]
29. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. Wu L; Rowley J; Mohades S; Leuzy A; Dauar MT; Shin M; Fonov V; Jia J; Gauthier S; Rosa-Neto P; PLoS One; 2012; 7(10):e47905. PubMed ID: 23112868 [TBL] [Abstract][Full Text] [Related]
32. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis. Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568 [TBL] [Abstract][Full Text] [Related]
33. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Kas A; Soret M; Pyatigoskaya N; Habert MO; Hesters A; Le Guennec L; Paccoud O; Bombois S; Delorme C; Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2543-2557. PubMed ID: 33452633 [TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease. Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635 [TBL] [Abstract][Full Text] [Related]
35. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment. Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664 [TBL] [Abstract][Full Text] [Related]
36. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment. Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443 [TBL] [Abstract][Full Text] [Related]